Stockreport

Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR

AKCEA THERAPEUTICS  (AKCA) 
Last akcea therapeutics earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akceatx.com/media-investors/press-releases
PDF  Akcea shareholders approved the transaction on April 16 at a Special Meeting of Stockholders               [Read more]